Sunflower Therapeutics Revenue and Competitors

Hingham, MA USA

Location

$4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sunflower Therapeutics's estimated annual revenue is currently $4.5M per year.(i)
  • Sunflower Therapeutics's estimated revenue per employee is $155,000
  • Sunflower Therapeutics's total funding is $4M.

Employee Data

  • Sunflower Therapeutics has 29 Employees.(i)
  • Sunflower Therapeutics grew their employee count by 7% last year.

Sunflower Therapeutics's People

NameTitleEmail/Phone
1
Founder, CEO/PresidentReveal Email/Phone
2
Chief People & Operations OfficerReveal Email/Phone
3
Chief People & Operations OfficerReveal Email/Phone
4
Director, Commercial OperationsReveal Email/Phone
5
Director Engineering OperationsReveal Email/Phone
6
Director R&DReveal Email/Phone
7
Software Product ManagerReveal Email/Phone
8
Lead Software EngineerReveal Email/Phone
9
Scientist - Strain Engineering & FermentationReveal Email/Phone
10
Lead Bioprocess EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Sunflower Therapeutics?

Sunflower Therapeutics is a unique biotechnology start-up focused on dramatically reducing the time and cost to develop and manufacture biologics for patients around the world. With a genetically-optimized host, data-driven process development, and a novel, ‘right-sized’ manufacturing unit, the experienced Sunflower team is creating an efficient, patient-centered, end-to-end drug production platform that we plan to deploy worldwide.

keywords:N/A

$4M

Total Funding

29

Number of Employees

$4.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.4M327%N/A
#2
$5.8M3228%N/A
#3
$5.3M383%N/A
#4
$5.1M39-11%N/A
#5
$8.4M39-35%N/A